MGMT and central nervous system cancer: Current available data generated from investigations in cell lines and tumor samples, suggest that resistance to temozolomide is significantly linked to MGMT-mediated DNA repair in high-grade gliomas, primitive neuroectodermal tumors, and ependymomas [20].